Project Details
Description
A Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type I
Status | Active |
---|---|
Effective start/end date | 12/9/21 → 1/1/26 |
Funding
- IMMUSOFT CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.